Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats

References

• Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG. 2007. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation. 116(19):2127–2138.
   PubMed Web of Science ®Google Scholar
• Chakraborti S, Pramanick A, Saha S, Roy SS, Chaudhuri AR, Das M, Ghosh S, Stewart A, Maity B. 2018. A typical G protein β5 promotes cardiac oxidative stress, apoptosis, and fibrotic remodeling in response to multiple cancer chemotherapeutics. Cancer Res. 78(2):528–541.
   PubMed Web of Science ®Google Scholar
• Chen L, Yang T, Lu DW, Zhao H, Feng YL, Chen H, Chen DQ, Vaziri ND, Zhao YY. 2018. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Biomed Pharmacother. 101:670–681.
   PubMed Web of Science ®Google Scholar
• Christia P, Frangogiannis NG. 2013. Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest. 43(9):986–995.
   PubMed Web of Science ®Google Scholar
• Croce CM. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10(10):704–714.
   PubMed Web of Science ®Google Scholar
• Cullen BR. 2006. Viruses and microRNAs. Nat Genet. 38(S6):S25–S30.
   PubMedGoogle Scholar
• Deng L, Huang L, Guo Q, Shi X, Xu K. 2017. CREB1 and Smad3 mediate TGF-β3-induced Smad7 expression in rat hepatic stellate cells. Mol Med Rep. 16(6):8455–8462.
   PubMed Web of Science ®Google Scholar
• Deten A, Holzl A, Leicht M, Barth W, Zimmer HG. 2001. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol. 33(6):1191–1207.
   PubMed Web of Science ®Google Scholar
• Deten A, Volz HC, Briest W, Zimmer HG. 2002. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res. 55(2):329–340.
   PubMed Web of Science ®Google Scholar
• Eser PÖ, Jänne PA. 2018. TGFβ pathway inhibition in the treatment of non-small cell lung cancer. Pharmacol Ther. 184:112–130.
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 9(2):102–114.
   PubMed Web of Science ®Google Scholar
• Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE. 2003. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc Res. 57(3):749–756.
   PubMed Web of Science ®Google Scholar
• He X, Zhang K, Gao X, Li L, Tan H, Chen J, Zhou Y. 2016. Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit. Heart Vessels. 31(10):1696–1708.
   PubMed Web of Science ®Google Scholar
• Katz LH, Likhter M, Jogunoori W, Belkin M, Ohshiro K, Mishra L. 2016. TGF-β signaling in liver and gastrointestinal cancers. Canc Lett. 379(2):166–172.
   PubMed Web of Science ®Google Scholar
• Latronico MV, Condorelli G. 2009. MicroRNAs and cardiac pathology. Nat Re Cardiol. 6:419–429.
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. 1993. The celegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75(5):843–854.
   PubMed Web of Science ®Google Scholar
• Li JM, Brooks G. 1997. Differential protein expression and subcellular distribution of TGFβ1, β2 and β3 in cardiomyocytes during pressure overload-induced hypertrophy. J Mol Cell Cardiol. 29(8):2213–2224.
   PubMed Web of Science ®Google Scholar
• Lipshultz SE, Miller TL, Scully RE, Lipsitz SR, Rifai N, Silverman LB, Colan SD, Neuberg DS, Dahlberg SE, Henkel JM, et al. 2012. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol. 30(10):1042–1049.
   PubMed Web of Science ®Google Scholar
• Liu G, Liu Y, Wang R, Hou T, Chen C, Zheng S, Dong Z. 2016. Spironolactone attenuates doxorubicin-induced cardiotoxicity in rats. Cardiovasc Ther. 34(4):216–224.
   PubMed Web of Science ®Google Scholar
• Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, Johnston WK, Wernig M, Newman J, et al. 2008. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell. 134(3):521–533.
   PubMed Web of Science ®Google Scholar
• Mauviel A. 2005. Transforming growth factor-beta: a key mediator of fibrosis. Meth Mol Med. 117:69–80.
   PubMedGoogle Scholar
• Mazevet M, Moulin M, Llach-Martinez A, Chargari C, Deutsch E, Gomez AM, Morel E. 2013. Complications of chemotherapy, a basic science update. Presse Med. 42(9):e352–e361.
   PubMedGoogle Scholar
• Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. 1996. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 94(7):1506–1512.
   PubMed Web of Science ®Google Scholar
• Nam NH. 2006. Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem. 6(8):945–951.
   PubMed Web of Science ®Google Scholar
• Nessa A, Latif SA, Siddiqui NI, Hussain MA, Bhuiyan MR, Hossain MA, Akther A, Rahman M. 2009. Angiogenesis-a novel therapeutic approach for ischemic heart disease. Mymensingh Med J. 18(2):264–272.
   PubMedGoogle Scholar
• Rosenkranz S. 2004. TGF-β1 and angiotensin networking in cardiac remodeling. Cardiovasc Res. 63(3):423–432.
   PubMed Web of Science ®Google Scholar
• Shabalala S, Muller CJF, Louw J, Johnson R. 2017. Polyphenols, autophagy and doxorubicin-induced cardiotoxicity. Life Sci. 180:160–170.
   PubMed Web of Science ®Google Scholar
• Tang WHW, Huang Y. 2013. Cardiotonic modulation in heart failure: insights from traditional Chinese medicine. J Am Coll Cardiol. 62(12):1073–1074.
   PubMed Web of Science ®Google Scholar
• Timmers L, van Keulen JK, Hoefer IE, Meijs MF, van Middelaar B, den Ouden K, van Echteld CJ, Pasterkamp G, de Kleijn DP. 2009. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Circ Res. 104(5):699–706.
   PubMed Web of Science ®Google Scholar
• Verjans R, Peters T, Beaumont FJ, van Leeuwen R, van Herwaarden T, Verhesen W, Munts C, Bijnen M, Henkens M, Diez J, et al. 2018. MicroRNA-221/222 family counteracts myocardial fibrosis in pressure overload-induced heart failure. Hypertension. 71(2):280–288.
   PubMed Web of Science ®Google Scholar
• Wang X, Li X, Ye L, Chen W, Yu X. 2013. Smad7 inhibits TGF-beta1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cells. Int Urol Nephrol. 45(3):899–907.
   PubMed Web of Science ®Google Scholar
• Wei LH, Huang XR, Zhang Y, Li YQ, Chen HY, Yan BP, Yu CM, Lan HY. 2013. Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling. Cardiovasc Res. 99(4):665–673.
   PubMed Web of Science ®Google Scholar
• Xie Z, Singh M, Singh K. 2004. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J Biol Chem. 279(38):39513–39519.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang Y, Zhu H, Hu J, Xie Z. 2018. MiR-34a/miR-93 target c-Ski to modulate the proliferaton of rat cardiac fibroblasts and extracellular matrix deposition in vivo and in vitro. Cell Signal. 46:145–153.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Yi M, Huang YP. 2017. Oxymatrine ameliorates doxorubicin-induced cardiotoxicity in rats. Cell Physiol Biochem. 43(2):626–635.
   PubMedGoogle Scholar
• Zou Y, Lin L, Ye Y, Gan T, An T, Zhang R, Wang Y, Huang Y, Zhou Q, Zhang J. 2012. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice. J Cardiovas Pharmacol. 59:268–280.
   PubMed Web of Science ®Google Scholar